Original Research

Published on 28 Nov 2023

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

in Cancer Immunity and Immunotherapy

Furong Kou
Jian Li
Yanshuo Cao
Zhi Peng
Ting Xu
Lin Shen
Jifang Gong
Xicheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1285478

1,206 views

Review

Published on 22 Nov 2023

Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy

in Cancer Immunity and Immunotherapy

Huaiyuan Zhang
Ziyuan Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1257515

2,970 views
4 citations

Mini Review

Published on 22 Nov 2023

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?

in Cancer Immunity and Immunotherapy

Arailym Sarsembayeva
Rudolf Schicho

Frontiers in Oncology

doi 10.3389/fonc.2023.1296906

4,341 views
4 citations

Original Research

Published on 22 Nov 2023

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Jonathan Khalifa
Noémie Thébault
Clara-Maria Scarlata
Emma Norkowski
Carole Massabeau
Laurent Brouchet
Sophie Peries Bataille
Christelle Casaroli
Liza Vaz
Carine Valle

Frontiers in Oncology

doi 10.3389/fonc.2023.1269166

1,953 views

Original Research

Published on 20 Nov 2023

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

in Cancer Immunity and Immunotherapy

Mariangela Garofalo
Magdalena Wieczorek
Ines Anders
Monika Staniszewska
Michal Lazniewski
Marta Prygiel
Aleksandra Anna Zasada
Teresa Szczepińska
Dariusz Plewczynski
Stefano Salmaso

Frontiers in Oncology

doi 10.3389/fonc.2023.1259314

2,925 views
2 citations

Review

Published on 16 Nov 2023

Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections

in Cancer Immunity and Immunotherapy

Diego Esperante
Mónica Itzel Martínez Gutiérrez
Mark E. Issa
Alejandro Schcolnik-Cabrera
Fela Mendlovic

Frontiers in Oncology

doi 10.3389/fonc.2023.1251355

1,822 views

Review

Published on 15 Nov 2023

The power of phages: revolutionizing cancer treatment

in Cancer Immunity and Immunotherapy

Md. Sharifull Islam
Jie Fan
Fan Pan

Frontiers in Oncology

doi 10.3389/fonc.2023.1290296

8,276 views
10 citations

Review

Published on 09 Nov 2023

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

in Cancer Immunity and Immunotherapy

Filomena Marino Carvalho

Frontiers in Oncology

doi 10.3389/fonc.2023.1244781

3,878 views
9 citations

Original Research

Published on 09 Nov 2023

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer

in Cancer Immunity and Immunotherapy

Rui Zhou
Fan Tong
Yongchang Zhang
Ruigang Zhang
Yawen Bin
Sheng Zhang
Nong Yang
Xiaorong Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1231094

1,729 views

Case Report

Published on 08 Nov 2023

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

in Cancer Immunity and Immunotherapy

Wei Cen Wang
Beatrice Preti
Nancy Read
Paul Gibson
Keith Kwan
Eric Winquist

Frontiers in Oncology

doi 10.3389/fonc.2023.1249453

1,448 views
2 citations

Editorial

Published on 08 Nov 2023

Editorial: Immune-related adverse events for patients with lung cancer-volume II

in Cancer Immunity and Immunotherapy

Yusha Wang
Xia Wang
Cheng Zhan
Benjamin Frey
Udo S. Gaipl
Hubing Shi
Xuelei Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1282394

891 views

Review

Published on 03 Nov 2023

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

in Cancer Immunity and Immunotherapy

Son Hai Vu
Ha Hong Pham
Thao Thi Phuong Pham
Thanh Thien Le
Manh-Cuong Vo
Sung-Hoon Jung
Je-Jung Lee
Xuan-Hung Nguyen

Frontiers in Oncology

doi 10.3389/fonc.2023.1275076

4,481 views
2 citations

Editorial

Published on 01 Nov 2023

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

in Cancer Immunity and Immunotherapy

Xiaoran Yin
Yan Feng
Bowen Zhang
Xueyan Mao
Siying Chen
Yuyan Wang
Sidney W. Fu

Frontiers in Oncology

doi 10.3389/fonc.2023.1301340

968 views

Original Research

Published on 01 Nov 2023

Genomic profiling and immune landscape of olfactory neuroblastoma in China

in Cancer Immunity and Immunotherapy

Yunyun Yang
Zhiyi Wan
Enli Zhang
Yingshi Piao

Frontiers in Oncology

doi 10.3389/fonc.2023.1226494

2,047 views
4 citations

Original Research

Published on 30 Oct 2023

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma

in Cancer Immunity and Immunotherapy

Xu Sun
Zhanpeng Liu
Qian Yu
Yinwei Chen
Yunwen Sun
Qingyi Zhu
Jian Yang
Rongjiang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1207551

1,975 views

Original Research

Published on 27 Oct 2023

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers

in Cancer Immunity and Immunotherapy

Chuang Yang
Patrick Sven Plum
Ines Gockel
René Thieme

Frontiers in Oncology

doi 10.3389/fonc.2023.1186101

2,053 views
3 citations

Navigation group

Articles

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections

The power of phages: revolutionizing cancer treatment

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

Editorial: Immune-related adverse events for patients with lung cancer-volume II

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

Genomic profiling and immune landscape of olfactory neuroblastoma in China

PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers